{"entity":{"type":"insider","cik":"0001791249","url":"/insider/0001791249","json_url":"/insider/0001791249.json","name":"Ackermann Michael","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":9,"first":"2021-08-06","last":"2022-05-09","span_basis":"filed_date"},"name_variants":[{"name":"Ackermann Michael","source":"filing","n_filings":9,"first_seen":"2021-08-06","last_seen":"2022-05-09"}],"transactions":[{"id":6823344,"accession":"0001209191-22-027856","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-027856","line_url":"/filing/0001209191-22-027856#line-1","is_derivative":false,"issuer_cik":"0001791249","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001791249","owner_cik":"0001791249","owner_name":"Ackermann Michael","owner_display_name":"Ackermann Michael","owner_url":"/insider/0001791249","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":13.5,"price_display":"13.50","price_state":"stated","total_value":1350000.0,"total_display":"1,350,000.00","total_whole":"1,350,000","shares_owned_after":100000.0,"shares_owned_after_display":"100,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-05","filed_date":"2022-05-09","scope":"insider"},{"id":4654697,"accession":"0001819790-21-000059","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001819790-21-000059","line_url":"/filing/0001819790-21-000059","is_derivative":false,"issuer_cik":"0001791249","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001791249","owner_cik":"0001791249","owner_name":"Ackermann Michael","owner_display_name":"Ackermann Michael","owner_url":"/insider/0001791249","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5833.0,"shares_display":"5,833","price_per_share":24.67588719355392,"price_display":"24.68","price_state":"stated","total_value":143934.45,"total_display":"143,934.45","total_whole":"143,934","shares_owned_after":1207407.0,"shares_owned_after_display":"1,207,407","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-01","filed_date":"2021-12-03","scope":"insider","n_lines":4},{"id":5032165,"accession":"0001819790-21-000043","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001819790-21-000043","line_url":"/filing/0001819790-21-000043","is_derivative":false,"issuer_cik":"0001791249","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001791249","owner_cik":"0001791249","owner_name":"Ackermann Michael","owner_display_name":"Ackermann Michael","owner_url":"/insider/0001791249","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5833.0,"shares_display":"5,833","price_per_share":27.8225715755186,"price_display":"27.82","price_state":"stated","total_value":162289.06,"total_display":"162,289.06","total_whole":"162,289","shares_owned_after":1210718.0,"shares_owned_after_display":"1,210,718","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-01","filed_date":"2021-11-03","scope":"insider","n_lines":2},{"id":5032156,"accession":"0001819790-21-000039","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001819790-21-000039","line_url":"/filing/0001819790-21-000039","is_derivative":false,"issuer_cik":"0001791249","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001791249","owner_cik":"0001791249","owner_name":"Ackermann Michael","owner_display_name":"Ackermann Michael","owner_url":"/insider/0001791249","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5633.0,"shares_display":"5,633","price_per_share":26.273674773655245,"price_display":"26.27","price_state":"stated","total_value":147999.61,"total_display":"147,999.61","total_whole":"148,000","shares_owned_after":1215682.0,"shares_owned_after_display":"1,215,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-12","filed_date":"2021-10-14","scope":"insider","n_lines":2},{"id":4337641,"accession":"0001819790-21-000035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001819790-21-000035","line_url":"/filing/0001819790-21-000035#line-1","is_derivative":false,"issuer_cik":"0001791249","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001791249","owner_cik":"0001791249","owner_name":"Ackermann Michael","owner_display_name":"Ackermann Michael","owner_url":"/insider/0001791249","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":25.03,"price_display":"25.03","price_state":"stated","total_value":5006.0,"total_display":"5,006.00","total_whole":"5,006","shares_owned_after":1221315.0,"shares_owned_after_display":"1,221,315","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-08","filed_date":"2021-10-12","scope":"insider"},{"id":4628669,"accession":"0001209191-21-054888","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-054888","line_url":"/filing/0001209191-21-054888#line-1","is_derivative":false,"issuer_cik":"0001791249","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001791249","owner_cik":"0001791249","owner_name":"Ackermann Michael","owner_display_name":"Ackermann Michael","owner_url":"/insider/0001791249","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5833.0,"shares_display":"5,833","price_per_share":25.242,"price_display":"25.24","price_state":"stated","total_value":147236.586,"total_display":"147,236.59","total_whole":"147,237","shares_owned_after":1221515.0,"shares_owned_after_display":"1,221,515","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-01","filed_date":"2021-09-03","scope":"insider"},{"id":5252361,"accession":"0001209191-21-051193","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-051193","line_url":"/filing/0001209191-21-051193#line-1","is_derivative":false,"issuer_cik":"0001791249","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001791249","owner_cik":"0001791249","owner_name":"Ackermann Michael","owner_display_name":"Ackermann Michael","owner_url":"/insider/0001791249","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":621.0,"shares_display":"621","price_per_share":25.152,"price_display":"25.15","price_state":"stated","total_value":15619.392,"total_display":"15,619.39","total_whole":"15,619","shares_owned_after":1227348.0,"shares_owned_after_display":"1,227,348","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-11","filed_date":"2021-08-12","scope":"insider"},{"id":4954704,"accession":"0001209191-21-050631","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-050631","line_url":"/filing/0001209191-21-050631#line-2","is_derivative":false,"issuer_cik":"0001791249","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001791249","owner_cik":"0001791249","owner_name":"Ackermann Michael","owner_display_name":"Ackermann Michael","owner_url":"/insider/0001791249","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":17500.0,"total_display":"17,500.00","total_whole":"17,500","shares_owned_after":1227969.0,"shares_owned_after_display":"1,227,969","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-09","filed_date":"2021-08-10","scope":"insider"},{"id":4954700,"accession":"0001209191-21-050631","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-050631","line_url":"/filing/0001209191-21-050631#line-1","is_derivative":false,"issuer_cik":"0001791249","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001791249","owner_cik":"0001791249","owner_name":"Ackermann Michael","owner_display_name":"Ackermann Michael","owner_url":"/insider/0001791249","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3129.0,"shares_display":"3,129","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":78225.0,"total_display":"78,225.00","total_whole":"78,225","shares_owned_after":1228669.0,"shares_owned_after_display":"1,228,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-06","filed_date":"2021-08-10","scope":"insider"},{"id":4341677,"accession":"0001209191-21-050177","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-050177","line_url":"/filing/0001209191-21-050177","is_derivative":false,"issuer_cik":"0001791249","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001791249","owner_cik":"0001791249","owner_name":"Ackermann Michael","owner_display_name":"Ackermann Michael","owner_url":"/insider/0001791249","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1383.0,"shares_display":"1,383","price_per_share":25.001084598698483,"price_display":"25.00","price_state":"stated","total_value":34576.5,"total_display":"34,576.50","total_whole":"34,577","shares_owned_after":1231998.0,"shares_owned_after_display":"1,231,998","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-05","filed_date":"2021-08-06","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001819790","name":"Tarsus Pharmaceuticals, Inc.","url":"/issuer/0001819790","role":"Director","n_filings":9,"first_seen":"2021-08-06","last_seen":"2022-05-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001791249","retrieved_at":"2026-08-24T06:03:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}